Carbonic Anhydrase II

Carbonic Anhydrase II

Carbonic Anhydrase II Overview

Molecule Name
Carbonic anhydrase II
Synonyms
CA2,CA-II,CAII,Car2
Drug Development Progress
Drugs in Clinical Trials1
Approved Drugs5
Highest Development StageApproved
Target Synonym
Carbonic anhydrase II,Carbonic Anhydrase B,EC:4.2.1.1,Carbonate Dehydratase II,Carbonic Anhydrase C,EC 4.2.1.1,CA2,Epididymis Luminal Protein 76,Car2,HEL-76,Epididymis Secretory Protein Li 282,CA-II,CAC,CAII,HEL-S-282,Carbonic Anhydrase 2,Carbonic Dehydratase
Background
Carbonic anhydrases (CAs) are a large family of zinc metalloenzymes. CAs form a family of enzymes that catalyze the rapid interconversion of carbon dioxide and water to bicarbonate and protons (or vice versa), a reversible reaction that occurs rather slowly in the absence of a catalyst. One of the functions of the enzyme in animals is to interconvert carbon dioxide and bicarbonate to maintain acid-base balance in blood and other tissues, and to help transport carbon dioxide out of tissues. The active site of most carbonic anhydrases contains a zinc ion. They are, therefore, classified as metalloenzymes. There are at least five distinct CA families (α, β, γ, δ and ε). These families have no significant amino acid sequence similarity and in most cases are thought to be an example of convergent evolution. The α-CAs are found in humans. Carbonic anhydrase II (CA2) is also known as Carbonate dehydratase II, Carbonic anhydrase C, is one of fourteen forms of human α carbonic anhydrases. Defects in this enzyme are associated with osteopetrosis and renal tubular acidosis. Renal carbonic anhydrase allows the reabsorption of sodium ions in the proximal tubule. Carbonic anhydrase II has been shown to interact with Band 3 and Sodium-hydrogen antiporter 1.

Carbonic Anhydrase II Product List

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
Topiramate (PrevEp)PrevEp-004Phase 2 ClinicalPrevEP Inc
Epilepsy, Benign Neonatal; Status Epilepticus
Details

Marketed Drug Information

English NameResearch CodeHighest Development StageCompanyFirst Brand NameFirst Approved CountryFirst IndicationFirst Approved CompanyFirst Approved DateIndicationClinical Trial
Brinzolamide/Timolol MaleateApprovedAlconAzarga, ElazopEUOcular Hypertension; Glaucoma, Open-AngleNovartis Europharm Ltd2008-11-25
Glaucoma; Glaucoma, Open-Angle; Ocular Hypertension
Details
SultiameRiker-594ApprovedDesitin Arzneimittel GmbhOspolotJapanEpilepsyKyowa Pharmaceutical Industry Co Ltd2001-12-01
Epilepsy; Sleep Apnea, Obstructive
Details
Brinzolamide/Brimonidine TartrateApprovedNovartis Pharma AgSimbrinzaUnited StatesOcular Hypertension; Glaucoma, Open-AngleAlcon Laboratories Inc2013-04-19
Glaucoma; Glaucoma, Open-Angle; Ocular Hypertension
Details
TopiramateSPN-538; KW-6485P; McN-4853; RWJ-17021; W-6485; TPM; USL-255ApprovedJohnson & Johnson Innovative Medicine妥泰, Topamax, Topina, Conviban, Qudexy, EprontiaUnited KingdomMigraine Disorders; EpilepsyJohnson & Johnson Innovative Medicine1995-01-01
Affective Disorders, Psychotic; Alcohol Drinking; Alcoholism; Binge-Eating Disorder; Bipolar Disorder; Brain Ischemia; Bulimia; Cocaine-Related Disorders; Cognition; Contraception; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Epilepsies, Partial; Epilepsy; Epilepsy, Absence; Epilepsy, Generalized; Epilepsy, Tonic-Clonic; Essential Tremor; Gambling; Headache; Heart Defects, Congenital; HIV Infections; Hyperlipidemias; Hypertension; Hypertriglyceridemia; Lennox Gastaut Syndrome; Lymphoma; Marijuana Abuse; Mental Disorders; Migraine Disorders; Migraine with Aura; Migraine without Aura; Mood Disorders; Obesity; Obesity, Morbid; Obsessive-Compulsive Disorder; Pain, Postoperative; Parkinson Disease; Pediatric Obesity; Peripheral Nervous System Diseases; Polyneuropathies; Sciatica; Seizures; Stress Disorders, Post-Traumatic; Tobacco Use Disorder; Tourette Syndrome; Vascular Headaches; Weight Loss
Details
BrinzolamideAL-4862; ALO-4862ApprovedAlcon派立明, AzoptUnited StatesOcular Hypertension; Glaucoma, Open-AngleSandoz1998-04-01
Glaucoma; Glaucoma, Open-Angle; Ocular Hypertension
Details